IOL Power Calculation After Radial Keratotomy Using the Haigis and Barrett True-K Formulas.

PURPOSE: To compare the accuracy of intraocular lens (IOL) power calculation in patients with previous radial keratotomy using the Haigis and Barrett True-K formulas. METHODS: In a retrospective cases series of patients with previous radial keratotomy and minimum follow-up of 1.2 months, preoperative data from an IOLMaster 500 or 700 (Carl Zeiss Meditec AG), the IOL power implanted, and the postoperative refraction were used to calculate the refractive prediction error. The primary outcomes were the mean absolute and arithmetic refractive prediction errors and the percentage of eyes with a refractive prediction error within ±0.50 and ±1.00 diopters (D). RESULTS: One hundred eight eyes were evaluated with a mean follow-up of 6.9 ± 4.9 months. The Haigis formula yielded a mean arithmetic refractive prediction error of -0.29 ± 1.00 D, which was significantly different than that of the Barrett True-K formula, which was -0.03 ± 0.96 D (P < .001). The mean absolute refractive prediction error was 0.80 ± 0.67 for the Haigis formula and 0.74 ± 0.60 for the Barrett True-K formula (P > .05). The percentages of eyes with a refractive prediction error within ±0.50 and ±1.00 D were 43.5% and 65.7% for the Haigis formula and 42.6% and 75.9% for the Barrett True-K formula, respectively (all P > .05). The subgroup analysis revealed that for flat corneas (K1 < 38.00 D), the Barrett True-K formula resulted in more hyperopic results than the Haigis formula. CONCLUSIONS: The Barrett True-K formula exhibited better arithmetic predictability than the Haigis formula; however, it showed a tendency for hyperopic results in very flat corneas. [J Refract Surg. 2020;36(12):832-837.].

Toric Artisan after transepithelial topography-guided photorefractive keratectomy for higher-order aberrations following intrastromal corneal ring segments in keratoconus - Trioptics.

We report a case of a 40-year-old female with keratoconus and high myopia who had previous ICRS implantation in both eyes (OU) and was intolerant to contact lenses. Manifest refraction was -8.50 -1.50 × 95 (20/25--) in right eye (OD) and -9.50 -2.50 × 60 (20/70--) in left eye (OS). A topography-guided transepithelial-photorefractive keratectomy (ttPRK) was performed to correct high-order aberrations on OS, resulting in corneal surface and coma improvement, and CDVA achieved 20/30. Correction of residual ametropia was performed with an iris-fixated toric phakic lens in OU. CDVA improved to 20/20- (Plano) in OD and 20/20- (Plano -1.00 90°) in OS. In conclusion, it is possible to rehabilitate a patient with keratoconus and high ametropia after intrastromal corneal ring segments (ICRS) implantation associating ttPRK and phakic lens ("Trioptics").

Late-onset corneal haze after intrastromal corneal ring implantation in an eye with previous topography-guided PRK.

PURPOSE: To report a case of late-onset corneal haze 3 months after intrastromal corneal ring segment (ICRS) implantation in an eye with previous transepithelial topography-guided photorefractive keratectomy (TG-PRK). OBSERVATIONS: A 40-year-old woman with stable keratoconus for 10 years underwent limited TG-PRK with mitomycin C in both eyes for mixed astigmatism. After four years, with atopic symptoms worsening and eye rubbing, the patient presented keratoconus progression in the left eye with increased irregular astigmatism. An ICRS was implanted with initial improvement in vision. Three months later severe subepithelial haze was observed along the ring groove. CONCLUSION AND IMPORTANCE: This is the first report of subepithelial haze after ICRS implantation. This report increases the evidence that permanent corneal wound healing changes occur after PRK and that late-onset haze may be triggered by corneal remodeling, as little inflammation or epithelial defect occurs after ICRS implantation. We do believe the detection of triggers, identification of risk factors of late-onset haze and appropriate preoperative counselling have an increasing importance due to the rising number of patients that have undergone PRK.

Focal phototherapeutic keratectomy for the treatment of apical leucoma syndrome / PTK focal para o tratamento da síndrome do leucoma apical

ABSTRACT The following report describes a case of apical leucoma syndrome after hyperopic photorefractive keratectomy following hyperopic laser in situ keratomileusis and the subsequent treatment of this complication with focal phototherapeutic keratectomy. The patient underwent focal transepithelial phototherapeutic keratectomy of 70 mm ablation and 1.5 mm diameter after pupil and ablation offset correction. After 1 year, significant improvement in vision was observed and only slight residual opacity remained on biomicroscopy and optical coherence tomography. Focal phototherapeutic keratectomy was effective and safe for the treatment of this complication.

RESUMO O relato a seguir descreve um caso da síndrome do Leucoma Apical após cirurgia ceratorrefrativa hipermetrópica depois de Laser hiperópico in situ keratomileusis, e o subsequente tratamento desta complicação com ceratectomia fototerapêutica focal. O paciente foi submetido à ceratectomia fototerapêutica focal transepitelial com ablação de 70 mm e diâmetro de 1,5 mm, após correção de offset pupilar. Depois de um ano, foi observada uma melhora significativa da acuidade visual permanecendo apenas leve opacidade residual na biomicroscopia e tomografia de coerência óptica. A ceratectomia fototerapêutica focal foi efetiva e segura para o tratamento desta complicação.

Focal phototherapeutic keratectomy for the treatment of apical leucoma syndrome.

The following report describes a case of apical leucoma syndrome after hyperopic photorefractive keratectomy following hyperopic laser in situ keratomileusis and the subsequent treatment of this complication with focal phototherapeutic keratectomy. The patient underwent focal transepithelial phototherapeutic keratectomy of 70 mm ablation and 1.5 mm diameter after pupil and ablation offset correction. After 1 year, significant improvement in vision was observed and only slight residual opacity remained on biomicroscopy and optical coherence tomography. Focal phototherapeutic keratectomy was effective and safe for the treatment of this complication.

Descemet membrane endothelial keratoplasty in multifocal pseudophakic eyes.

PURPOSE: This report describes the use of Descemet membrane endothelial keratoplasty for the management of endothelial decompensation after multifocal intraocular lens implantation. METHODS: In this retrospective study, we reviewed and assessed the surgical outcomes of 9 patients (9 eyes) who underwent Descemet membrane endothelial keratoplasty after multifocal intraocular lens implantation. RESULTS: Corneal edema occurred due to Fuchs endothelial corneal dystrophy (n=3), pseudophakic bullous keratopathy (n=3), Descemet's membrane detachment (n=2), and toxic anterior segment syndrome (n=1). The Descemet membrane endothelial keratoplasty surgeries were uneventful in all eyes, but rebubbling procedures were necessary in 2 eyes. One month after the surgery, all the corneas were clear. After 6 months, excluding 1 eye with amblyopia, the mean distance corrected visual acuity was 0.10 logMAR, with all eyes achieving 0.18 logMAR or better. CONCLUSIONS: This is the first report of Descemet membrane endothelial keratoplasty after multifocal intraocular lens implantation, and it suggests that good results can be achieved without multifocal intraocular lens exchange.

Descemet membrane endothelial keratoplasty in multifocal pseudophakic eyes / Ceratoplastia endotelial da membrana de Descemet em olhos pseudofácicos multifocais

ABSTRACT Purpose: This report describes the use of Descemet membrane endothelial keratoplasty for the management of endothelial decompensation after multifocal intraocular lens implantation. Methods: In this retrospective study, we reviewed and assessed the surgical outcomes of 9 patients (9 eyes) who underwent Descemet membrane endothelial keratoplasty after multifocal intraocular lens implantation. Results: Corneal edema occurred due to Fuchs endothelial corneal dystrophy (n=3), pseudophakic bullous keratopathy (n=3), Descemet's membrane detachment (n=2), and toxic anterior segment syndrome (n=1). The Descemet membrane endothelial keratoplasty surgeries were uneventful in all eyes, but rebubbling procedures were necessary in 2 eyes. One month after the surgery, all the corneas were clear. After 6 months, excluding 1 eye with amblyopia, the mean distance corrected visual acuity was 0.10 logMAR, with all eyes achieving 0.18 logMAR or better. Conclusions: This is the first report of Descemet membrane endothelial keratoplasty after multifocal intraocular lens implantation, and it suggests that good results can be achieved without multifocal intraocular lens exchange.

RESUMO Objetivo: Descrever o uso da ceratoplastia endotelial da membrana de Descemet para manejar descompensação endotelial após implante de lente intraocular multifocal. Métodos: Neste estudo retrospectivo, foram revisados e avaliados os resultados cirúrgicos de 9 olhos de 9 pacientes que foram submetidos a ceratoplastia endotelial da membrana de Descemet para manejar descompensação endotelial após implante de lente intraocular multifocal. Resultados: Descompensação endotelial ocorreu por distrofia endotelial de Fuchs (n=3), ceratopatia bolhosa do pseudofácico (n=3), descolamento da membrana de Descemet (n=2) e síndrome tóxica do segmento anterior (n=1). No ato per operatório de todos os olhos não houve intercorrência, com injeção de ar sendo necessário em dois olhos no pós-operatório por descolamento parcial do enxerto. Um mês após a cirurgia, todas as córneas estavam claras. Após seis meses, excluindo um olho com ambliopia, a acuidade visual média corrigida para longe foi de 0,10 logMAR, com todos os olhos atingindo 0,18 logMAR ou melhor. Conclusões: Este é o primeiro relato de ceratoplastia endotelial da membrana de Descemet após implante de lente intraocular multifocal, sugerindo que bons resultados podem ser alcançados sem a troca da lente intraocular multifocal.

Net technique for intraocular lens support in aphakia without capsular support.

BACKGROUND: This paper describes a modified surgical technique for intraocular lens implantation in aphakic eyes with no capsular support. METHODS: Retrospective case series. Seventeen eyes of 17 aphakic patients with no capsule support underwent intraocular lens (IOL) implantation using a standardized technique in which a net was created at the ciliary sulcus plane with two threads forming a net pattern. The net was used as support for the IOL. Follow-up ranged from 6 to 38 months, with an average of 23 months. RESULTS: In all cases, the IOL was safely implanted and remained stable during the follow-up. In 16 eyes, the IOL remained well centered; in one eye, slight decentration was observed. Distance-corrected visual acuity improved by a mean of 4 lines, from 1.13 (LogMAR) to 0.52 (P = 0.01). CONCLUSION: This technique might be especially useful in cases of insufficient capsular support associated with tissue loss or iris atrophy. In these cases, iris fixation is not feasible; thus, the only surgical alternative is IOL scleral fixation.

Removal of Persistent Cellular Deposits After Foldable Iris-Fixated Phakic IOL Implantation.

PURPOSE: To report a case of severe recurrent cellular deposits after Artiflex intraocular lens (Ophtec B. V., Groningen, The Netherlands) implantation. METHODS: Case report. RESULTS: A 25-year-old woman underwent uneventful Artiflex intraocular lens implantation in both eyes. After 3 months, severe cellular deposits were seen in the posterior surface of the lens in one eye. Topical steroids were administered, with temporary improvement. Four months later, the deposits recurred and did not respond to topical steroids. Corrected distance visual acuity lost five lines. Treatment by polishing the posterior surface of the lens 10 months after the initial implantation was performed and resulted in complete visual recovery. No recurrence of the deposits were observed after 2 years of follow-up. CONCLUSIONS: Persistent cellular deposits after Artiflex intraocular lens implantation may cause severe visual loss and may need surgical intervention. Polishing the posterior surface of the lens to mechanically remove the deposits was an effective long-term solution. [J Refract Surg. 2017;33(6):426-428.].

Photorefractive Keratectomy With Mitomycin C in Meesmann's Epithelial Corneal Dystrophy.

PURPOSE: To describe a case of Meesmann's epithelial corneal dystrophy that underwent photorefractive keratectomy (PRK) with mitomycin C. METHODS: Case report. RESULTS: A 36-year-old woman was evaluated for refractive surgery. She had a history of recurrent epithelial erosions and moderate visual loss over the past 10 years. Biomicroscopy revealed bilateral micro-cystic epithelial lesions and a diagnosis of Meesmann's epithelial corneal dystrophy was proposed. Corneal optical coherence tomography showed epithelial thickening with apparent intraepithelial cysts in the superficial layers. The patient's daughter's examination showed the same biomicroscopy pattern. PRK was performed. Epithelial healing was uneventful and only tiny microcysts could be observed after 3 months. However, complete recurrence of the intraepithelial cysts were observed after 1 year with visual acuity dropping due to residual refractive error. CONCLUSIONS: This case suggests that residual refractive error and recurrence of the cystic lesions and punctate erosions should be anticipated after PRK in patients with Meesmann's epithelial corneal dystrophy. [J Refract Surg. 2017;33(1):53-55.].

Effect of Topical Tacrolimus in the Treatment of Thygeson's Superficial Punctate Keratitis.

PURPOSE: To evaluate topical tacrolimus ointment for treating Thygeson's superficial punctate keratitis (Thygeson SPK). DESIGN: Retrospective interventional case series. METHODS: setting: Institutional practice. PATIENT POPULATION: The medical records of 14 patients (9 women; age range, 9-65 years) with Thygeson SPK were reviewed retrospectively. Diagnosis was based on the history and clinical examination. INTERVENTION: Patients were treated with tacrolimus 0.03% eye ointment instilled into the lower fornix twice daily for the first 2 weeks, followed by nocturnal application. The clinical signs and symptoms were assessed after 1 month of treatment. The drug was tapered with disease improvement. MAIN OUTCOME MEASURE(S): Treatment efficacy and side effects. RESULTS: All patients had bilateral disease (average duration, 6 years). All patients, except 2 who used the medication irregularly, had improved visual acuity (VA), symptoms, and signs as long as the medication was applied. Before treatment 28.57% of patients had VA between 20/30 and 20/50, with improvement after treatment to 20/25 or 20/20. Attempts to withdraw the medication resulted in recurrent disease, and, therefore, treatment was not curative during the study period. No significant local medication side effects were reported. CONCLUSION: Tacrolimus eye ointment 0.03% was effective for controlling Thygeson SPK for a long period with good patient tolerance and no noticeable local or systemic side effects. During the average 6-year follow-up, treatment was not curative. Randomized studies are difficult to conduct because of the disease rarity.

Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.

PURPOSE: To describe the use of topical 0.03% tacrolimus in patients with symptomatic corneal subepithelial infiltrates (SEIs) secondary to adenoviral keratoconjunctivitis (AK) that were resistant to tapering of corticosteroid eye drops. METHODS: This was a prospective, nonrandomized, noncomparative interventional case series that included consecutive patients treated with tacrolimus for resistant SEIs after AK. The patients had active SEIs and corrected distance visual acuity (CDVA) of 20/25 or worse when treatment was initiated. The recorded data included age, sex, CDVA, intraocular pressure, duration and intensity of symptoms, biomicroscopy findings, and duration of therapy. The treatment was considered successful if there was a reduction in SEIs, as well as CDVA stabilization or improvement. The treatment was considered unsuccessful if the patient could not tolerate tacrolimus or if there was an increase in SEIs. RESULTS: Seven patients were included (10 eyes). The mean age was 36.7 ± 12.3 years. The mean duration of tacrolimus therapy was 8.8 ± 2.4 months, and the mean duration of follow-up was 13.6 ± 10.7 months. Treatment was successful in 8 eyes of 6 patients. One patient could not tolerate the medication. Statistically significant improvement in the CDVA was observed (from a mean of 0.29 to 0.07) (P = 0.001). No statistically significant changes in the intraocular pressure were observed (P = 0.574). SEI scores showed a significant reduction from 2.20 ± 0.92 to 0.25 ± 0.46 (P = 0.011). All patients who completed treatment had improvement in ocular symptoms. CONCLUSIONS: Topical 0.03% tacrolimus seemed to be an effective corticosteroid-sparing agent for the treatment of SEIs after AK.

Moderate keratoconus with thick corneas.

PURPOSE: To describe two patients with moderate keratoconus and a corneal thickness exceeding 600 µm at the thinnest point. METHODS: Case report. RESULTS: In the first case, the steepest keratometric power was 51.50 diopters (D) in the right eye and 53.4 in the left eye and the thickness at the thinnest point was 658 and 625 µm, respectively. In the second case, the steepest keratometric power was 46.70 D in the right eye and 49.60 D in the left eye and the thickness at the thinnest point was 618 and 608 µm, respectively. CONCLUSIONS: Keratoconus may develop despite a very thick cornea, reinforcing the idea that biomechanical changes can signify an important factor in the development and progression of this pathology.

Nodular epithelial hyperplasia after photorefractive keratectomy followed by corneal collagen cross-linking.

This study describes a case of nodular epithelial hyperplasia and stromal alterations in a patient with keratoconus who was submitted to topography-guided photorefractive keratectomy (PRK) followed by corneal collagen cross-linking. Debridement of the epithelial nodule was performed. After a 2-year followup, a new topography-guided PRK was indicated.

[Safety of photorefractive keratectomy with mitomycin-C for the treatment of hyperopia after radial keratotomy]. / Segurança da ceratectomia fotorrefrativa com mitomicina-C para o tratamento de hipermetropia após ceratotomia radial.

PURPOSE: To evaluate the safety of photorefractive keratectomy (PRK) with mitomycin-C (MMC) in eyes with hyperopia after radial keratotomy. METHODS: Sixty eyes of 36 consecutive patients treated with corneal wavefront-guided PRK using an Esiris-Schwind excimer laser were prospectively evaluated. Corneal epithelium was mechanically removed, followed by photoablation and use of 0.02% MMC for 20 or 40 seconds. In 16 eyes (26.7%), MMC was applied for 40 seconds. These eyes underwent ablations deeper than 100 micron or had previous corneal sutures. Patients were followed up for 12 months. RESULTS: The mean spherical equivalent (SE) before PRK was +4.27 D +/- 2.18, and the mean best corrected visual acuity (BCVA) was 0.174 +/- 0.139 (logMAR). The planned laser SE correction was +4.74 D +/- 2.11, resulting in an ablation depth of 78 +/- 28 microm (from 33 to 148). No intraoperative complications were observed. At one year, mean SE was +0.04 D +/- 1.03 (p<0.001) and mean BCVA was 0.079 +/- 0.105 (p<0.001). There was a gain of 2 or more lines of BCVA in 20 eyes (33.3%) and only one eye (1.7%) lost 2 lines. Correlation analysis showed that the improvement in BCVA was inversely related to preoperative BCVA (r=-0.694; p<0.001). Five eyes developed peripheral haze grade 2 or 3 and one eye had central trace haze. No significant correlation was found between central or peripheral haze and the number of radial incisions, depth of the ablation or postoperative BCVA. Mean preoperative endothelial cell count was 2,681 +/- 455 cel/ mm(2) and after one year was 2,481 +/- 378 cel/mm(2) (p=0.124). One eye developed keratectasia due to the progressive widening of an inferior radial incision, which was later sutured. CONCLUSION: PRK with MMC was safe after one year of follow-up for the reduction of hyperopia after radial keratotomy. A major improvement in BCVA was obtained with a small incidence of haze and other complications.

[Corneal wavefront-guided photorefractive keratectomy with mitomycin-C for consecutive hyperopia after radial keratotomy]. / Ceratectomia fotorrefrativa com mitomicina-C personalizada pela frente de onda corneana para o tratamento de hipermetropia após ceratotomia radial.

PURPOSE: To assess the efficacy, predictability and stability of corneal wavefront-guided photorefractive keratectomy (PRK) for correcting hyperopia and astigmatism after radial keratotomy. METHODS: In a prospective study, 60 eyes of 36 consecutive patients were treated with corneal wavefront-guided PRK with 0.02% mitomycin-C using an Esiris-Schwind excimer laser. Corneal epithelium was mechanically removed. All patients were followed-up for 12 months. RESULTS: The mean time between radial keratotomy and PRK was 18.4 years +/- 3.8 (SD); mean spherical equivalent (SE) before radial keratotomy was -4.35 diopters (D) +/- 1.55. Before PRK, the mean sphere was +5.00 D +/- 2.28, mean astigmatism was - 1.47 D +/- 1.06, mean SE was +4.27 D +/- 2.18, and the mean best-corrected visual acuity (BCVA) was 0.174 +/- 0.139 (logMAR). The planned laser SE correction was +4.74 D +/- 2.11. No intraoperative complications were noted. At 12 months, mean SE was +0.04 D +/- 1.03 (P<0.001), mean astigmatism was -1.03 +/- 0.75 D (P=0.015), mean UCVA was 0.265 +/- 0.197, and mean BCVA was 0.079 +/- 0.105 (P<0.001). There was a mean gain of 1 line of BCVA and 20 eyes (33.3%) gained 2 or more lines. Only one eye lost 2 lines. A significant decrease in coma (P=0.002), trefoil (P=0.004), spherical aberration (P<0.001) and quatrefoil (P=0.002) was observed. Forty eight eyes (80%) were within +/- 1.0 D of intended SE. Mean regression from 6 to 12 months was +0.17 +/- 0.67 D. CONCLUSION: Corneal wavefront-guided PRK was effective, predictable and stable after one year of follow-up for the treatment of hyperopia after radial keratotomy. A significant improvement in UCVA, BCVA and corneal aberrations was obtained. ClinicalTrials.gov Identifier: NCT00917657.

Segurança da ceratectomia fotorrefrativa com mitomicina-C para o tratamento de hipermetropia após ceratotomia radial / Safety of photorefractive keratectomy with mitomycin-C for the treatment of hyperopia after radial keratotomy

OBJETIVO: Analisar a segurança da ceratectomia fotorrefrativa (PRK) com mitomicina-C (MMC) em olhos com hipermetropia consecutiva à ceratotomia radial. MÉTODOS: Foram avaliados prospectivamente 60 olhos de 36 pacientes consecutivos, submetidos à ceratectomia fotorrefrativa personalizada pela frente de onda corneana com o laser Esiris Schwind. Realizaram-se desepitelização mecânica, seguida da fotoabla ção, e utilização de MMC 0,02 por cento por 20 ou 40 segundos. Em 16 olhos (26,7 por cento) a MMC foi aplicada por 40 segundos. Estes foram submetidos a ablações mais profundas do que 100 micra ou apresentavam córneas submetidas a suturas prévias. Os pacientes foram acompanhados por um ano. RESULTADOS: O equivalente esférico (EE) médio antes do PRK era +4,27 D ± 2,18 e a acuidade visual corrigida (AVcc) média era 0,174 ± 0,139 (logMAR). O EE médio programado no laser foi +4,74 D ± 2,11, resultando em uma profundidade de ablação de 78 ± 28 µm (de 33 a 148). Não foram observadas complicações intraoperatórias. Após um ano observaram-se: EE médio de + 0,04 D ± 1,03 (p<0,001) e AVcc de 0,079 ± 0,105 (p<0,001). Observou-se melhora de duas ou mais linhas de AVcc em 20 olhos (33,3 por cento) e somente 1 olho (1,7 por cento) perdeu duas linhas. A análise de correlação mostrou que a melhora da AVcc foi inversa mente correlacionada à AVcc pré-operatória (r=-0,694; p<0,001). ''Haze'' periférico grau 2 ou 3 foi observado em cinco olhos e ''haze'' central discreto, em um olho. Não houve correlação significativa do ''haze'' central ou periférico com o número de incisões radiais, com a profun didade da fotoablação ou com a AVcc pós-operatória. A contagem endotelial média no pré-operatório foi de 2.681± 455 cel/mm2 e após 1 ano foi de 2.481 ± 378 cel/mm2 (p=0,124). Um olho desenvolveu ectasia corneana, devido ao alargamento progressivo de uma incisão radial inferior, e foi submetido à sutura da incisão. CONCLUSÃO: O PRK com MMC mostrou-se seguro após um ...

PURPOSE: To evaluate the safety of photorefractive keratectomy (PRK) with mitomycin-C (MMC) in eyes with hyperopia after radial keratotomy. METHODS: Sixty eyes of 36 consecutive patients treated with corneal wavefront-guided PRK using an Esiris-Schwind excimer laser were prospectively evaluated. Corneal epithelium was mechanically removed, followed by photoablation and use of 0.02 percent MMC for 20 or 40 seconds. In 16 eyes (26.7 percent), MMC was applied for 40 seconds. These eyes underwent ablations deeper than 100 micron or had previous corneal sutures. Patients were followedup for 12 months. RESULTS: The mean spherical equivalent (SE) before PRK was +4.27 D ± 2.18, and the mean bestcorrected visual acuity (BCVA) was 0.174 ± 0.139 (logMAR). The planned laser SE correction was +4.74 D ± 2.11, resulting in an ablation depth of 78 ± 28 µm (from 33 to 148). No intraoperative complications were observed. At one year, mean SE was +0.04 D ± 1.03 (p<0.001) and mean BCVA was 0.079 ± 0.105 (p<0.001). There was a gain of 2 or more lines of BCVA in 20 eyes (33.3 percent) and only one eye (1.7 percent) lost 2 lines. Correlation analysis showed that the improvement in BCVA was inversely related to preoperative BCVA (r=-0.694; p<0.001). Five eyes developed peripheral haze grade 2 or 3 and one eye had central trace haze. No significant correlation was found between central or peripheral haze and the number of radial incisions, depth of the ablation or postoperative BCVA. Mean preoperative endothelial cell count was 2,681 ± 455 cel/ mm² and after one year was 2,481 ± 378 cel/mm² (p=0.124). One eye developed keratectasia due to the progressive widening of an inferior radial incision, which was later sutured. CONCLUSION: PRK with MMC was safe after one year of follow-up for the reduction of hyperopia after radial keratotomy. A major improvement in BCVA was obtained with a small incidence of haze and other complications.

Ceratectomia fotorrefrativa com mitomicina-C personalizada pela frente de onda corneana para o tratamento de hipermetropia após ceratotomia radial / Corneal wavefront-guided photorefractive keratectomy with mitomycin-C for consecutive hyperopia after radial keratotomy

OBJETIVO: Avaliar a eficácia, previsibilidade e estabilidade da ceratectomia fotorrefrativa (PRK) guiada pela frente de onda corneana para o tratamento da hipermetropia secundária à ceratotomia radial. MÉTODOS: Este estudo prospectivo analisou 60 olhos de 36 pacientes consecutivos, submetidos a PRK personalizado com o laser Esiris-Schwind. A técnica constou de desepitelização mecânica, fotoablação e utilização de mitomicina-C 0,02 por cento. Os pacientes foram acompanhados por 12 meses. RESULTADOS: O intervalo médio entre a ceratotomia radial e o PRK foi de 18,4 anos ± 3,8 (DP); o equivalente esférico (EE) médio antes da ceratotomia radial era -4,35 dioptrias (D) ± 1,55. As medidas prévias ao PRK mostraram grau esférico médio de +5,00 D ± 2,28, astigmatismo médio de -1,47 D ± 1,06, EE médio de +4,27 D ± 2,18 e AV corrigida (AVcc) média de 0,174 ± 0,139 (logMAR). O EE médio programado no laser foi +4,74 D ± 2,11. Os resultados encontrados um ano após a cirurgia foram: EE médio de +0,04 D ± 1,03 (P<0,001), astigmatismo médio de -1,03 ± 0,75 D (P=0,015), AV média sem correção de 0,265 ± 0,197 e AVcc de 0,079 ± 0,105 (P<0,001). A AVcc mostrou ganho médio de uma linha; 20 olhos (33,3 por cento) melhoraram duas ou mais linhas e somente um olho perdeu duas linhas. Ocorreu redução estatisticamente significante do coma (P=0,002), trefoil (P=0,004), aberração esférica (P<0,001) e quatrefoil (P=0,002). Houve 48 olhos (80 por cento) entre ± 1,00 D do EE planejado. A regressão média entre seis e 12 meses foi de +0,17 ± 0,67 D. CONCLUSÃO: O PRK personalizado pela frente de onda corneana foi eficaz, previsível e estável pelo período de um ano para a redução da hipermetropia após a ceratotomia radial. No pós-operatório, observou-se melhora significativa da AVsc, AVcc e das aberrações corneanas. Número do ClinicalTrials.gov:NCT00917657

PURPOSE: To assess the efficacy, predictability and stability of corneal wavefront-guided photorefractive keratectomy (PRK) for correcting hyperopia and astigmatism after radial keratotomy. METHODS: In a prospective study, 60 eyes of 36 consecutive patients were treated with corneal wavefront-guided PRK with 0.02 percent mitomycin-C using an Esiris-Schwind excimer laser. Corneal epithelium was mechanically removed. All patients were followed-up for 12 months. RESULTS: The mean time between radial keratotomy and PRK was 18.4 years ± 3.8 (SD); mean spherical equivalent (SE) before radial keratotomy was -4.35 diopters (D) ± 1.55. Before PRK, the mean sphere was +5.00 D ± 2.28, mean astigmatism was - 1.47 D ± 1.06, mean SE was +4.27 D ± 2.18, and the mean best-corrected visual acuity (BCVA) was 0.174 ± 0.139 (logMAR). The planned laser SE correction was +4.74 D ± 2.11. No intraoperative complications were noted. At 12 months, mean SE was +0.04 D ± 1.03 (P<0.001), mean astigmatism was -1.03 ± 0.75 D (P=0.015), mean UCVA was 0.265 ± 0.197, and mean BCVA was 0.079 ± 0.105 (P<0.001). There was a mean gain of 1 line of BCVA and 20 eyes (33.3 percent) gained 2 or more lines. Only one eye lost 2 lines. A significant decrease in coma (P=0.002), trefoil (P=0.004), spherical aberration (P<0.001) and quatrefoil (P=0.002) was observed. Forty eight eyes (80 percent) were within ± 1.0 D of intended SE. Mean regression from 6 to 12 months was +0.17 ± 0.67 D. CONCLUSION: Corneal wavefront-guided PRK was effective, predictable and stable after one year of follow-up for the treatment of hyperopia after radial keratotomy. A significant improvement in UCVA, BCVA and corneal aberrations was obtained. ClinicalTrials.gov Identifier: NCT00917657

Ceractomia fotorrefrativa (PRK) com mitomicina C baseada na análise de frentes de onda corneanas para o tratamento da hipermetropia consecutiva à ceratotomia radial / Corneal wavefront-guided photorefractive keratectomy (PRK) with adjunctive mitomycin C (MMC) for the treatment of hyperopia after radial keratotomy

OBJETIVO: Avaliar a eficácia, estabilidade, previsibilidade e segurança da ceratectomia fotorrefrativa (PRK) guiada pelas frentes de onda corneana para o tratamento da hipermetropia secundária à ceratotomia radial (CR). MÉTODOS: Foram avaliados prospectivamente 61 olhos de 39 pacientes consecutivos, submetidos a PRK personalizado com o laser Esiris-Schwind. A técnica constou de desepitelização mecânica, fotoablação, e utilização de mitomicina C (MMC) 0,02% por 20 ou 40 segundos. A MMC foi aplicada por 40 segundos em 17 olhos (27,9%) que haviam sido submetidos a ablações mais profundas do que 100 ?m ou apresentavam córneas previamente suturadas. As avaliações pós-operatórias foram realizadas após sete dias, um, seis, 12 e 24 meses. Todos os olhos foram avaliados após um ano e dois anos. RESULTADOS: O intervalo médio entre a CR e o PRK foi de 18,8 anos ± 3,8 (DP); o equivalente esférico (EE) médio antes da ceratotomia radial era -4,10 dioptrias (D) ± 1,44. As medidas prévias ao PRK mostraram EE médio de +4,17 D ± 1,97; astigmatismo médio de -1,39 D ± 1,04; AV com correção (AVcc) média de 0,161 ± 0,137 (logMAR); e curvatura corneana média de 35,85 ± 3,60 D. Os resultados encontrados dois anos após a cirurgia foram: EE médio de 0,14 ± 0,99 D (p < 0,001); astigmatismo médio de -1,19 ± 1,02 D (p = 0,627); AV sem correção (AVsc) média de 0,265 ± 0,196 (p < 0,001); AVcc média de 0,072 ± 0,094 (p < 0,001); e curvatura corneana média de 39,01 ± 3,18 D (p < 0,001). AVsc igual ou melhor a 20/25 foi observada em 38% dos olhos e igual ou melhor a 20/40 em 69%. A AVcc melhorou em 62,3% dos olhos, sendo que 21 olhos (34,4%) melhoraram uma linha e outros 17 olhos (27,9%), duas ou mais linhas. Um olho (1,6%) perdeu duas linhas devido ao astigmatismo irregular ocasionado por opacificação corneana periférica. Outro olho perdeu três linhas pelo desenvolvimento de ectasia corneana entre seis e 24 meses, devido ao alargamento progressivo de uma incisão radial inferior...

PURPOSE: To assess the efficacy, stability, predictability and safety of corneal wavefront-guided photorefractive keratectomy (PRK) for correcting hyperopia after radial keratotomy (RK). METHODS: In a prospective study, 61 eyes of 39 consecutive patients were treated with PRK using an Esiris-Schwind excimer laser. Corneal epithelium was mechanically removed, followed by photoablation and use of 0.02% mitomycin C (MMC) for 20 or 40 seconds. MMC was used for 40 seconds in 18 eyes (27.9%) which underwent ablations deeper than 100 micron or had previous corneal sutures. Postoperative evaluations were performed after seven days, six, 12 and 24 months. All patients were followed up for two years. RESULTS: The mean time between RK and PRK was 18.8 years ± 3.8 (SD); mean spherical equivalent (SE) before RK was -4.10 diopters (D) ± 1.44. Before PRK, the mean SE was +4.17 D ± 1.97, mean astigmatism was -1.39 D ± 1.04, the mean best-corrected visual acuity (BCVA) was 0.161 ± 0.137 (logMAR) and the mean corneal curvature was 35.85 ± 3.60 D. At 24 months, mean SE was 0.14 ± 0.99 D (p < 0.001), mean astigmatism was -1.19 ± 1.02 D (p = 0.627), mean UCVA was 0.265 ± 0.196 (p < 0.001), mean BSCVA was 0.072 ± 0.094 (p < 0.001) and the mean corneal curvature was 39.01 ± 3.18 D (p < 0.001). UCVA was 20/25 or better in 38% of eyes and 20/40 or better in 69%. BCVA improved in 62.3% of eyes, with 21 (34.4%) gaining one line and 17 (27.9%), two or more lines. One eye (1.6%) lost two lines due to irregular astigmatism and peripheral haze. Another eye lost three lines due to keratectasia occurring between six and 24 months resulting from widening of an inferior radial incision that was later sutured. Thirty eyes (49.2%) were within ± 0.50 D of intended SE and 45 (73.8%) were within ± 1.00 D. From six to 24 months, the mean SE...